Physician profile
Anthony Cavallo
NPI 1932461936
$8,535.80
in general payments reported to CMS, 2019-2025
15 companies · $1,561 in 2025
The $1,561 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $473 · 2021: $1,054 · 2022: $2,283 · 2023: $1,312 · 2024: $1,105 · 2025: $1,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,978.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,624.56 | 2019-2025 | Augment Injectable, Citrefix, Variax |
| Fortis Surgical, LLC | $1,359.32 | 2019-2023 | |
| Kerecis Limited | $1,043.69 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Lifenet Health | $374.81 | 2023-2025 | Theragenesis Wound Matrix |
| Depuy Synthes Sales INC. | $305.79 | 2023 | Na, Hammerlock, Motoband |
| Misonix INC | $185.11 | 2020-2021 | |
| Convatec INC. | $136.75 | 2024 | |
| Crossroads Extremity Systems, LLC | $107.87 | 2019-2021 | |
| Paragon 28, INC. | $107.03 | 2022 | |
| Treace Medical Concepts, INC. | $106.48 | 2025 | |
| Fusion Orthopedics USA, LLC | $87.27 | 2025 | |
| Bioventus LLC | $33.00 | 2022 | |
| Tactile Systems Technology INC | $26.32 | 2019 | |
| Osiris Therapeutics INC. | $22.06 | 2019 | |
| Anika Therapeutics, INC. | $15.74 | 2025 | Tactoset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cavallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.